Taking a neurological history

References 

1. Knecht S, Dräge B, Deppe M, et al. Handedness and hemispheric language dominance in healthy humans. Brain. 2000;123:2512–2518
   • CrossRef
2. Hoefnagels WAJ, Padberg GW, Overweg J, Velde EA, Roos RAC. Transient loss of consciousness: the value of the history for distinguishing seizure from syncope. J Neurol. 1991;238:39–43
   • MEDLINE
   • CrossRef
3. Herzog AG. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure. 2008;17:151–159
   • Abstract
   • Full Text
   • Full-Text PDF (328 KB)
   • CrossRef
4. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351–353
   • CrossRef
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
   • MEDLINE
   • CrossRef
6. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J. 1965;14:61–65
   • MEDLINE
7. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127
   • MEDLINE
   • CrossRef
8. Loveman E, Green C, Kirby J, et al. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer’s disease. Health Technol Assess. 2006;10:1–160
   • MEDLINE
9. Koppel BS. Contribution of drugs and drug interactions (prescribed, over the counter, and illicit) to seizures and epilepsy. In:  Ettinger AB,  Devinsky O editor. Managing epilepsy and co-existing disorders. Boston: Butterworth-Heinemann; 2002;
10. Quinn NP. How to diagnose multiple system atrophy. Mov Disord. 2005;20(Suppl 12):S5–S10
    • CrossRef